Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Carcinoma
Interventions: DRUG: Carboplatin|DRUG: Paclitaxel|DRUG: Bevacizumab|DRUG: Trastuzumab|DRUG: Pertuzumab
Sponsor: University of California, Irvine